Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer

Androgen deprivation therapy (ADT) has been the standard care for patients with advanced prostate cancer (PC) since the 1940s. Although ADT shows clear benefits for many patients, castration-resistant prostate cancer (CRPC) inevitably occurs. In fact, with the two recent FDA-approved second-generati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojo, Diane, Lin, Xiaozeng, Wong, Nicholas, Gu, Yan, Tang, Damu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695890/
https://www.ncbi.nlm.nih.gov/pubmed/26593949
http://dx.doi.org/10.3390/cancers7040890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695890/
https://www.ncbi.nlm.nih.gov/pubmed/26593949
http://dx.doi.org/10.3390/cancers7040890

Ejemplares similares